atl001
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 15, 2019 (NCT03997474)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04785365 | N/A | Jul 1, 2021 | Achilles Therapeutics Ltd |
| NCT04032847 | Phase 1/Phase 2 (Phase 2) | Jul 8, 2019 | Achilles Therapeutics Ltd |
| NCT03997474 | Phase 1/Phase 2 (Phase 2) | Jun 15, 2019 | Achilles Therapeutics Ltd |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Achilles Therapeutics Ltd | For profit | 3 | 3 | 2 | 2019 |
1 organizations
Page 1 / 1